hotspot -WSS

hotspot

author：focus 2025-09-27 09:58:26 - browse：48393

Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT — Adobe

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

“One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Senators tussle over abortion against the backdrop of a presidential campaign

explore

hotspot

WSS

Medicare Advantage's lean provider networks lead CMS complaints

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Fight over Supreme Court dialysis ruling puts kidney patients at risk

UnitedHealth CEO's Medicaid comments send insurer stocks diving

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Senators tussle over abortion against the backdrop of a presidential campaign

leisure time

hotspot

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Emergency medicine has repudiated 'excited delirium.' Now what?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: What happened with Sarepta's Duchenne data

How one medical school became remarkably diverse

Physician subsidies by hospitals soar in wake of No Surprises Act

Malaria cases in Florida and Texas: Here’s what you need to know

Stopping antidepressants leads to symptoms for 1 in 6 patients

Apple is now the first public company to be valued at $3 trillion

The FDA weighs the risks of candy

hotspot

Maker of FluMist seeks to allow at

Structure Therapeutics oral GLP

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Readout Newsletter: New research from Sanofi, Regeneron, etc.

First Opinion Podcast: How to protect health care in times of war

The most pressing bird flu mysteries scientists want answered

explore

focus

hotspot

leisure time